Tag: MIPS

Biosimilars Naming

Regulations and EHRs: All Pain and No Gain?

By Michael Burger, EDI and EHR Practice Lead I recently read a summary of a Capitol Hill hearing that focused on the impact of healthcare’s administrative burden on costs and …